Clinical Study

A Randomized Trial Of Pelvic Irradiation With Or Without Concurrent Weekly Cisplatin In Patients With Pelvic-Only Recurrence Of Carcinoma Of The Uterine Corpus

Posted Date: Feb 28, 2018

  • Investigator: Eric Eisenhauer
  • Specialties:
  • Type of Study: Drug

The main purpose of this study is to compare radiation therapy in combination with weekly treatment with the chemotherapy drug cisplatin to the standard treatment for this type of cancer to see which is better. The standard treatment for patients with your type of cancer is radiation therapy alone. Radiation therapy is a cancer treatment that uses radiation beams from outside your body, or radioactive seeds or pellets placed directly into the tissue to kill cancer cells. Radiation therapy alone has not been very effective in treating large tumors that recur (come back) in the pelvis, lymph nodes or vagina. Radiation therapy in combination with weekly treatment with the chemotherapy drug cisplatin has been found to be very effective in treating patients with advanced cervical cancers. Another purpose of the study is to evaluate the side effects of the combination of radiation therapy and cisplatin.


You Are Being Asked To Take Part In This Research Study Because You Are 18 Years Of Age Or Older And You Have Been Diagnosed With Recurrent Uterine Cancer (Cancer That Has Come Back).


Gynecologic Oncology, Gynecology, Radiation, Recurrent, Uterine Cancer

For More Information:

Michael Blakeman

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.